Phase II Trial of Single-Agent Bevacizumab Followed by...

Journal of Clinical Oncology 2009 / 02 Vol. 27; Iss. 5

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., Garren, N., Mackey, M., Butman, J. A., Camphausen, K., Park, J., Albert, P. S., Fine, H. A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2008.16.3055
Date:
February, 2009
File:
PDF, 575 KB
english, 2009
Conversion to is in progress
Conversion to is failed